IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $775,000 | +40.9% | 16,700 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $550,000 | -40.0% | 16,700 | -50.0% | 0.00% | 0.0% |
Q2 2020 | $916,000 | -63.7% | 33,400 | -60.3% | 0.00% | -66.7% |
Q1 2020 | $2,520,000 | +232.0% | 84,200 | -1.9% | 0.01% | +100.0% |
Q4 2018 | $759,000 | -34.6% | 85,795 | -16.9% | 0.00% | -25.0% |
Q3 2018 | $1,161,000 | -12.1% | 103,195 | 0.0% | 0.00% | -20.0% |
Q2 2018 | $1,321,000 | -7.7% | 103,195 | +21.8% | 0.01% | -16.7% |
Q1 2018 | $1,431,000 | -73.3% | 84,703 | -87.3% | 0.01% | -71.4% |
Q4 2017 | $5,352,000 | +3.1% | 668,975 | -0.1% | 0.02% | -4.5% |
Q3 2017 | $5,189,000 | +4.0% | 669,587 | -1.4% | 0.02% | -4.3% |
Q2 2017 | $4,989,000 | – | 678,767 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |